Evaluation of Transperineal US in Labour
Sponsor
Aljazeera Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03471780
Collaborator
Kasr El Aini Hospital (Other)
600
1
15
40
Study Details
Study Description
Brief Summary
Assessment of progress of labour is an important step in decision making of obstetricians
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
delayed progress of labour resemble an annoying problem to obstetrician so noninvasive diagnostic methods can play an important role in implementing a guidelines to follow patients in labour as transperineal US .
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
600 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Importance of Transperineal US in Labour
Actual Study Start Date
:
Jan 8, 2018
Anticipated Primary Completion Date
:
Apr 10, 2019
Anticipated Study Completion Date
:
Apr 10, 2019
Outcome Measures
Primary Outcome Measures
- the number of participants who will deliver by normal delivery [within 24 hours]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
pregnant women in labour
-
Full term
Exclusion Criteria:
-
pregnant ladies not in labour
-
Preterm labour
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Algazeerah | Giza | Egypt |
Sponsors and Collaborators
- Aljazeera Hospital
- Kasr El Aini Hospital
Investigators
- Principal Investigator: Mahmoud Alalfy, Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Mahmoud Alalfy,
Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital,
Aljazeera Hospital
ClinicalTrials.gov Identifier:
NCT03471780
Other Study ID Numbers:
- labour US
First Posted:
Mar 21, 2018
Last Update Posted:
Jan 9, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No